Cargando…

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy

Graves' disease (GD) and ophthalmopathy (GO) are organ-specific autoimmune-inflammatory disorders characterized by a complex pathogenesis. The inflammatory process is dominated by an imbalance of the antioxidant-oxidant mechanism, increased production of radical oxygen species (ROS), and cytoki...

Descripción completa

Detalles Bibliográficos
Autor principal:	Duntas, Leonidas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270443/ https://www.ncbi.nlm.nih.gov/pubmed/22315699 http://dx.doi.org/10.1155/2012/736161

Ejemplares similares

Selenium and at-risk pregnancy: challenges and controversies
por: Duntas, Leonidas H.
Publicado: (2020)

Update on the medical treatment of Graves’ ophthalmopathy
por: Griepentrog, Gregory J, et al.
Publicado: (2009)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
por: Chatziralli, Irini P., et al.
Publicado: (2010)

Review of the treatment of Graves’ ophthalmopathy: The role of the new radiation techniques
por: San Miguel, Iñigo, et al.
Publicado: (2018)

Immunological Aspects of Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2019)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Radiotherapy in the treatment of Graves ophthalmopathy—to do it or not?
por: Zygulska, Aneta
Publicado: (2009)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Advances in Graves' Disease
por: Galofré, Juan C., et al.
Publicado: (2012)

The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves’ Ophthalmopathy
por: Hou, Tzu-Yu, et al.
Publicado: (2021)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

Pregnancy, thyroid, and the potential use of selenium
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2019)

The relationship between Graves’ ophthalmopathy and dry eye syndrome
por: Selter, Jessica H, et al.
Publicado: (2014)

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
por: Jarusaitiene, Dalia, et al.
Publicado: (2016)

The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
por: Steinbrenner, Holger, et al.
Publicado: (2022)

Graves' Ophthalmopathy: A Review of Immunogenetics
por: Khalilzadeh, Omid, et al.
Publicado: (2011)

Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
por: Ahn, Hwa Young, et al.
Publicado: (2020)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Exploring the Role of SRC in Extraocular Muscle Fibrosis of the Graves’ Ophthalmopathy
por: Hao, Mingyu, et al.
Publicado: (2020)

Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management
por: Barrio-Barrio, Jesús, et al.
Publicado: (2015)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy
por: Miot, Hélio Amante, et al.
Publicado: (2009)

Severe Grave's Ophthalmopathy–missed for many years
por: Wani, Mohd Maqbool, et al.
Publicado: (2010)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The association of carotid cavernous fistula with Graves’ ophthalmopathy
por: Celik, Ozlem, et al.
Publicado: (2013)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
por: BOSKOVIC, OLIVERA, et al.
Publicado: (2020)

Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy
por: Ueland, Hans Olav, et al.
Publicado: (2023)

Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves’ disease and Graves’ ophthalmopathy
por: Tsai, Kun-Hsi, et al.
Publicado: (2012)

Prevalence of Graves’ ophthalmopathy in patients with Graves’ disease presenting to a referral centre in north India
por: Reddy, Sagili Vijaya Bhaskar, et al.
Publicado: (2014)

The critical role of m(6)A methylation in the pathogenesis of Graves' ophthalmopathy
por: Zhu, Li, et al.
Publicado: (2020)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves’ ophthalmopathy: a review
por: Shanmuganathan, Thayalini, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lvs8jk3hi4skb0b6q81gdijddn